Carr-Brendel V - Search Results

1

Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.

de Zoeten E, Carr-Brendel V, Markovic D, Taylor-Papadimitriou J, Cohen EP. de Zoeten E, et al. Among authors: carr brendel v. J Immunol. 1999 Jun 1;162(11):6934-41. J Immunol. 1999. PMID: 10352316

2

Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma.

Xu W, de Zoeten E, Carr-Brendel V, Cohen EP. Xu W, et al. Among authors: carr brendel v. Cancer Immunol Immunother. 1998 Jan;45(5):217-24. doi: 10.1007/s002620050436. Cancer Immunol Immunother. 1998. PMID: 9439644 Free PMC article.

3

Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.

de Zoeten EF, Carr-Brendel V, Cohen EP. de Zoeten EF, et al. Among authors: carr brendel v. J Immunol. 1998 Mar 15;160(6):2915-22. J Immunol. 1998. PMID: 9510195

4

Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanoma.

Sun T, Carr-Brendel V, De Zoeten EF, Cohen EP. Sun T, et al. Among authors: carr brendel v. Cancer Gene Ther. 1998 Mar-Apr;5(2):110-8. Cancer Gene Ther. 1998. PMID: 9570302

5

Immunity to breast cancer in mice immunized with X-irradiated breast cancer cells modified to secrete IL-12.

Carr-Brendel V, Markovic D, Smith M, Taylor-Papadimitriou J, Cohen EP. Carr-Brendel V, et al. J Immunother. 1999 Sep;22(5):415-22. doi: 10.1097/00002371-199909000-00005. J Immunother. 1999. PMID: 10546157

6

Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.

Carr-Brendel V, Markovic D, Ferrer K, Smith M, Taylor-Papadimitriou J, Cohen EP. Carr-Brendel V, et al. Cancer Res. 2000 May 1;60(9):2435-43. Cancer Res. 2000. PMID: 10811121

7

Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents.

Brauker J, Frost GH, Dwarki V, Nijjar T, Chin R, Carr-Brendel V, Jasunas C, Hodgett D, Stone W, Cohen LK, Johnson RC. Brauker J, et al. Among authors: carr brendel v. Hum Gene Ther. 1998 Apr 10;9(6):879-88. doi: 10.1089/hum.1998.9.6-879. Hum Gene Ther. 1998. PMID: 9581910

8

Transplantation of cells in an immunoisolation device for gene therapy.

Carr-Brendel VE, Geller RL, Thomas TJ, Boggs DR, Young SK, Crudele J, Martinson LA, Maryanov DA, Johnson RC, Brauker JH. Carr-Brendel VE, et al. Methods Mol Biol. 1997;63:373-87. doi: 10.1385/0-89603-481-X:373. Methods Mol Biol. 1997. PMID: 9113663 No abstract available.

9

Neovascularization of immunoisolation membranes: the effect of membrane architecture and encapsulated tissue.

Brauker J, Martinson LA, Hill RS, Young SK, Carr-Brendel VE, Johnson RC. Brauker J, et al. Transplant Proc. 1992 Dec;24(6):2924. Transplant Proc. 1992. PMID: 1281580 No abstract available.

10

Neovascularization of synthetic membranes directed by membrane microarchitecture.

Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Brauker JH, et al. Among authors: carr brendel ve. J Biomed Mater Res. 1995 Dec;29(12):1517-24. doi: 10.1002/jbm.820291208. J Biomed Mater Res. 1995. PMID: 8600142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters